NEW YORK (AVAFIN) -- Block trades serve as a useful indicator for investors trying to understand the sentiment of large financial institutions. A total of 45 block trades were executed today, typically at least 10,000 shares or more represent a single block unit. Further analysis into the trading activity reveals that 539,833 shares were bought and 391,132 shares were sold. The bought/sold ratio for shares of MannKind is 1.38, representing a positive net cash flow of $1,023,389 into the stock.

View all Block Trading Activities


Institutional investors also took positions in options where a total of 18,411 contracts was traded. Specifically, 15,025 call and 3,386 put contracts were traded during the last session yielding a 0.23 put/call ratio.

Afrezza has demonstrated a much more favorable side-effect profile compared with injectable insulin therapy. Long-term safety data also indicate that the product does not cause a decrease in lung function. Additionaly, MannKind plans to price Afrezza at parity with insulin analogs and has developed its device to fit comfortably in the palm, which should help remedy the reimbursement and design issues encountered by Exubera.

Shares of MannKind closed at $7.23, up $0.44 (+6.48%) in the last trading session. Today's volume of 10M shares is greater than the average volume of 4M shares. MNKD is trading above the 50 day moving average and higher than the 200 day moving average. The stock's 52 week low is $1.57 and 52 week high is $4.50.

http://www.avafin.com/articles/1024425.html